PTSD

World Renowned International Psychedelics Experts Join Clarion Clinics Advisory Board

Retrieved on: 
Tuesday, May 30, 2023
IHL, Clarion, Benzodiazepine, California Institute for Regenerative Medicine, Johns Hopkins School of Medicine, California Institute of Integral Studies, Caffeine, Psychedelic drug, Johns Hopkins University, Patient, Principal, Psilocybin, Emergency medicine, GHB, Principal investigator, Research, Private practice, Certification, Terminal, Cocaine, Psychedelic therapy, The MINDS Foundation, Psychiatry, Cannabis, Addiction, MDA, DPT, NIH, PTSD, Depression, Sunstone, DSM-IV codes, LSD, Alcoholism, Advisory board, Ketamine, Johns Hopkins Center for Health Security, Behavioural sciences, Johns Hopkins, Economics, Yoga, Methamphetamine, ASX, Consciousness, Trust, CQD, Dextromethorphan, Medical director, Episode, MDMA, Pharmaceutical industry, Nursing

MELBOURNE, Australia, May 30, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’), a pharmaceutical company developing proprietary drugs which use cannabis as an ingredient for unmet medical needs, psychedelic-assisted psychotherapy protocols, and an operator of psychedelic-assisted psychotherapy clinics, is pleased to announce that three of the world’s top psychedelic therapy and science experts have joined the Advisory Board of Clarion Clinics Group.

Key Points: 
  • Three world-leading clinical psychedelics experts join Clarion Clinics Advisory Board.
  • The company is delighted to announce that, in addition to the most experienced psychedelics professionals in Australia taking key executive roles and directorships in the Clarion Clinics Group, three of the world’s most experienced and leading clinical psychedelic experts have joined its Advisory Board.
  • Andrea serves as the Medical Director of the OVID Clinics in Berlin, and is a co-founder and advisory board member of the MIND Foundation.
  • I’m grateful for their trust and support.”
    Peter Widdows, Incannex Director, said: “I’m delighted and honoured that such esteemed professionals have decided to join the Clarion Clinics team.

Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreement and Provides Update on Its Board of Directors

Retrieved on: 
Tuesday, May 30, 2023
Senior, London Stock Exchange, Subscription business model, Offering, Engineering, OTC, Bush School of Government and Public Service, NEO Exchange, Mental health, NEO, PTSD, Security (finance)

The Company also announced today the closing of the first tranche of the first issuance under the Subscription Agreement (the “Offering”).

Key Points: 
  • The Company also announced today the closing of the first tranche of the first issuance under the Subscription Agreement (the “Offering”).
  • The Offering resulted in the issuance of 1,515,151 Shares at a price of $0.33 per Share for aggregate gross proceeds of $500,000.
  • The Company also announced that Mr. Todd Heinzl has been re-appointed to the board of directors of the Company.
  • The Company welcomes Mr. Heinzl back to the board of directors.

COHEN VETERANS BIOSCIENCE JOINS VETERAN MATTHEW MITCHELL ON MILITARY MAKEOVER WITH MONTEL TO DISCUSS TRAUMATIC BRAIN INJURY

Retrieved on: 
Tuesday, May 30, 2023
Trauma, United States Marine Corps Wounded Warrior Regiment, Depression, Senate, Therapy, Army, Traumatic brain injury, Woman, EST, Veteran, Research, TBI, Brain, Doctor of Philosophy, Centers for Disease Control and Prevention, Science, Arms, CVB, MD, Marines, Navy, Makeover, Diagnosis, IED, Family, PTSD, Management

NEW YORK, May 30, 2023 /PRNewswire/ -- On Friday, June 2, 2023, at 7:30AM EST, Cohen Veterans Bioscience CEO and President Dr. Magali Haas, will appear on the latest episode of Military Makeover to discuss the "invisible wounds", state of the science and pursuits to advance treatments related to traumatic brain injury (TBI).

Key Points: 
  • Military Makeover with Montel® offers hope and a helping hand to members of our military and their loved ones.
  • Show host and military advocate Montel Williams, a veteran of both the Marine Corps and the Navy, leads the Makeover team's mission.
  • Dr. Magali Haas meets with U.S. Army Staff Sergeant veteran Matthew Mitchell to listen to his experience and discuss the latest science pursuits for those affected by Traumatic Brain Injury and PTSD.
  • "The effects of Traumatic Brain Injury should never be underestimated and I fully support the advancements in science Cohen Veterans Bioscience is leading", said Staff Sergeant Mitchell.

Choose Ketamine Expands Access to Ketamine Therapy Covering Over 50% of the US

Retrieved on: 
Tuesday, May 30, 2023
Telehealth, Depression, Choose, PHE, Anxiety, COVID-19, DSM-IV codes, Disorder, Ketamine, DEA, KAT, Patient, Southeastern United States, PTSD, Nursing, Pharmaceutical industry

The leadership at Choose Ketamine is highly optimistic as they continue to improve access to transformative ketamine therapy, allowing patients to be safely treated in the comfort of their own homes.

Key Points: 
  • The leadership at Choose Ketamine is highly optimistic as they continue to improve access to transformative ketamine therapy, allowing patients to be safely treated in the comfort of their own homes.
  • Offering ketamine therapy in Arizona gives Choose Ketamine complete coverage of the southwest.
  • Bringing ketamine therapy to Georgia marks Choose Ketamine's growth in the region where it now serves 34% of the southeastern United States.
  • The expansion moves Choose Ketamine one step closer to the ultimate mission of making affordable, convenient, and responsible at-home ketamine therapy available nationwide.

SKULLCANDY UNVEILS "ALL LOVE" HEADPHONES AHEAD OF PRIDE MONTH IN SUPPORT OF LGBTQIA+ COMMUNITY

Retrieved on: 
Tuesday, May 30, 2023
Partnership, Depression, To Write Love on Her Arms, Skullcandy, Suicide, Tech, Movement, Self-harm, Workshop, Anxiety disorder, Love, Addiction, Trauma, Drapht, Mental health, PARK, PTSD, TWLOHA, Video game, Nursing, Marketing

PARK CITY, Utah, May 30, 2023 /PRNewswire/ -- Skullcandy announced today its limited-edition "All Love" Crusher Evo Headphones in partnership with To Write Love on Her Arms (TWLOHA), a nonprofit movement dedicated to presenting hope and finding help for people struggling with depression, addiction, self-injury and suicide. The limited-edition headphones feature a Pride-inspired colorway designed to celebrate all love, all year long. The Skullcandy "All Love'' Edition Crusher Evo headphones will begin selling May 30, exclusively on Skullcandy.com. A portion of proceeds will help To Write Love on Her Arms fund mental health support programs designed specifically for the LGBTQIA+ community.

Key Points: 
  • The limited-edition headphones feature a Pride-inspired colorway designed to celebrate all love, all year long.
  • The Skullcandy "All Love'' Edition Crusher Evo headphones will begin selling May 30, exclusively on Skullcandy.com.
  • A portion of proceeds will help To Write Love on Her Arms fund mental health support programs designed specifically for the LGBTQIA+ community.
  • "Skullcandy actively champions mental health, with a focus on supporting programs dedicated to the LGBTQ+ community during this time of year," said Justin Regan, VP of Marketing, Skullcandy.

Camp Southern Ground Hosts 3rd Annual Farm + Table Benefit Featuring Caroline Jones

Retrieved on: 
Thursday, May 25, 2023
Learning, Food, GRAMMY, Depression, Life, Autism spectrum, Anxiety, Family Camp, Zac Brown Band, Veteran, CSG, PTSD, Tourism, Nursing

The afternoon gathering on Camp Southern Ground’s campus raised funds to directly help Camp Southern Ground serve more kids, veterans, and military families.

Key Points: 
  • The afternoon gathering on Camp Southern Ground’s campus raised funds to directly help Camp Southern Ground serve more kids, veterans, and military families.
  • During summer months, Camp Southern Ground (CSG), located about 30 miles south of Atlanta, is an inclusive, residential summer camp for youth.
  • During the rest of the year, Camp Southern Ground is dedicated to supporting veterans and their families.
  • “We are proud that each meal served at Camp Southern Ground is supplemented by produce from our organic garden.

Tonix Pharmaceuticals Announces the Isolation and Characterization of the (S)-Isomer of Tianeptine, TNX-4300 (Estianeptine), Now Under Development for Psychiatric and Neurodegenerative Diseases

Retrieved on: 
Tuesday, May 23, 2023
Cognition, Psychiatry, Neuron, Tonix Pharmaceuticals, Acute stress disorder, Depression, Diabetes, PPAR, CNS, Weight gain, DSM-IV codes, Bipolar disorder, MDD, Asian Pacific Development Center, RDC, Research, PTSD, Pharmaceutical industry

CHATHAM, N.J., May 23, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the isolation and functional characterization of the two mirror image isomers of racemic tianeptine, which is marketed outside the U.S. as a treatment for major depressive disorder (MDD). Tonix scientists discovered that the (S)-isomer of tianeptine activates PPAR-β/δ, restores neuroplasticity in neuronal tissue culture and is free of µ-opioid receptor activity. In contrast, (R)-tianeptine activates the µ-opioid receptor and lacks PPAR-β/δ activity. Based on these discoveries, Tonix has begun preclinical development of the (S)-isomer, TNX-4300 (estianeptine)*, as a treatment for MDD, bipolar disorder, Alzheimer’s disease, and Parkinson’s disease. Tonix is planning to submit data supporting tianeptine’s mechanism of action for presentation at upcoming scientific conferences and for publication in peer reviewed journals.

Key Points: 
  • Tonix scientists discovered that the (S)-isomer of tianeptine activates PPAR-β/δ, restores neuroplasticity in neuronal tissue culture and is free of µ-opioid receptor activity.
  • In contrast, (R)-tianeptine activates the µ-opioid receptor and lacks PPAR-β/δ activity.
  • Based on these discoveries, Tonix has begun preclinical development of the (S)-isomer, TNX-4300 (estianeptine)*, as a treatment for MDD, bipolar disorder, Alzheimer’s disease, and Parkinson’s disease.
  • Tonix is planning to submit data supporting tianeptine’s mechanism of action for presentation at upcoming scientific conferences and for publication in peer reviewed journals.

Terran Biosciences announces new breakthroughs in the chemistry of MDMA and its enantiomers and analogs, discovers new salts and polymorphs, publishes PCT application.

Retrieved on: 
Friday, May 26, 2023
MDAI, Therapy, MEAI, PTSD, PCT, MDE, Literature, Patent, Post-traumatic stress disorder, Patient, USE, MBDB, Empathy, Terran, SALTS, MDMA, MDEA, Pharmaceutical industry

MDMA is the most studied empathogen to date and has been shown to be an effective treatment for post-traumatic stress disorder (PTSD) in multiple phase 3 trials.

Key Points: 
  • MDMA is the most studied empathogen to date and has been shown to be an effective treatment for post-traumatic stress disorder (PTSD) in multiple phase 3 trials.
  • Historically, MDMA has only been developed as a single salt and the crystal structures of its enantiomers had not been characterized.
  • As previously reported, Terran found that the S enantiomer of MDEA had significant advantages over the (R)-MDEA in preclinical models.
  • Terran is also developing the S enantiomer of MBDB which was shown to have significant advantages over (R)-MBDB in preclinical models.

Cohen Veterans Network Announces Memorial Day Toolkit; Urges Americans to Consider the True Meaning of the Day

Retrieved on: 
Thursday, May 25, 2023
Depression, Freedom, Anxiety, CVN, Anger, Veteran, Cohen Veterans Network, Grief, Mental, Memorial, Memorial Day, Family, Social media, PTSD, Nursing, Tourism

STAMFORD, Conn., May 25, 2023 /PRNewswire/ -- Many Americans mark Memorial Day weekend with barbecues and vacations and are quick to "celebrate" by telling friends and family, "Happy Memorial Day." But this year, as we enjoy the freedoms earned through the sacrifice of our service members, Cohen Veterans Network (CVN), a not-for-profit philanthropic organization that serves post-9/11 veterans, service members and their families through a nationwide system of mental health clinics, is encouraging Americans to consider the true meaning of the day – intended to honor and remember those who have served and died. To support this effort, CVN has developed a new Memorial Day Toolkit with information and resources to further our nation's understanding about the day and encourage support for the military community.

Key Points: 
  • STAMFORD, Conn., May 25, 2023 /PRNewswire/ -- Many Americans mark Memorial Day weekend with barbecues and vacations and are quick to "celebrate" by telling friends and family, "Happy Memorial Day.
  • To support this effort, CVN has developed a new Memorial Day Toolkit with information and resources to further our nation's understanding about the day and encourage support for the military community.
  • "For many, Memorial Day has become the unofficial start to summer," says Cohen Veterans Network President & CEO Dr. Anthony Hassan.
  • "But as we enjoy the holiday weekend, we must not lose sight of the profound purpose of Memorial Day.

SourceAmerica Announces 2023 Achievement Award Winners Celebrating Inclusivity for People with Disabilities

Retrieved on: 
Thursday, May 25, 2023
Workforce, McDade, Pentagon, Small business, Unemployment, Partnership, Chicago Innovation Awards, Life, Disability, Workplace, COVID-19, OR, ECHO, Cape Liptrap Lighthouse, Schriever Space Force Base, Veteran, Person, Patrick Space Force Base, Griffin, United States Department of Veterans Affairs, Camping, PTSD, Safety, Injury, X-Force, Nursing, Management, Lemma Senbet Fund, SourceAmerica

The SourceAmerica achievement awards recognize nonprofits, employees, and business partners for their exceptional work ethic, success, and leadership in advancing inclusion for people with disabilities.

Key Points: 
  • The SourceAmerica achievement awards recognize nonprofits, employees, and business partners for their exceptional work ethic, success, and leadership in advancing inclusion for people with disabilities.
  • "People with disabilities bring unique insights and talents to the nation's workforce," said Richard Belden, SourceAmerica president and chief executive officer.
  • "SourceAmerica takes pride in celebrating the achievements of these award winners who have demonstrated leadership, dedication, and the passion to inspire others to work towards a more inclusive workforce."
  • Learn more about the outstanding accomplishments of the 2023 Achievement Award winners:
    One of Telisha Griffin's co-workers describes her as "a smile that can light up a room."